Get the Stockscreener App
4.12
3.77%
0.14
Candel Therapeutics Inc Stock (CADL) Forecast
The Candel Therapeutics Inc (CADL) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $6.2535, representing a +51.78% increase from the current price of $4.12. The highest analyst price target is $6.8257, and the lowest is $5.6813.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CADL Price Target
Average 5.4237
(+31.64% Upside)
Is Candel Therapeutics Inc (CADL) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 28.71 | Buy |
| STOCH(9,6) | 15.29 | Buy |
| STOCHRSI(14) | 64.85 | Neutral |
| MACD(12,26) | -0.5221 | Sell |
| ADX(14) | 29.54 | Sell |
| William %R | -79.15 | Neutral |
| CCI(14) | -62.54 | Neutral |
Buy: 2
Sell: 2
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
4.2395
Sell
|
4.2852
Sell
|
| MA20 |
4.787
Sell
|
4.6965
Sell
|
| MA50 |
5.8552
Sell
|
5.395
Sell
|
| MA100 |
5.9137
Sell
|
5.6996
Sell
|
| MA200 |
5.6644
Sell
|
5.1575
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, CADL could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 12 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on CADL, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 28.71 indicates that CADL is oversold. This indicates that CADL price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 15.29 indicates that CADL is oversold. This indicates that CADL price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 64.85 indicates that CADL is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 29.54 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -62.54 indicates that CADL is still oversold but not to an extreme extent.
Long-term CADL price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Candel Therapeutics Inc financial reports and earnings history, Candel Therapeutics Inc (CADL) stock could reach $5.151 by 2030, $21.23 by 2040 and $20.51 by 2050. See the projected annual prices until 2050 of the Candel Therapeutics Inc stock below:
- Candel Therapeutics Inc (CADL) is expected to reach an average price of $9.3086 in 2035, with a high prediction of $9.8843 and a low estimate of $8.9975. This indicates an $125.94% rise from the last recorded price of $4.12.
- Candel Therapeutics Inc (CADL) stock is projected to chart a bullish course in 2040, with an average price target of $20.13, representing an $388.49% surge from its current level. The forecast ranges from a conservative $19.52 to a sky-high $21.23.
- Our analysts predict Candel Therapeutics Inc (CADL) to jump 270.63% by 2045, soaring from $15.05 to an average price of $15.27, potentially reaching $15.63. While $15.05 is the low estimate, the potential upside is significant.
- Candel Therapeutics Inc (CADL) stock is expected to climb by 2050, reaching an average of $20.51, a $397.93% jump from its current level. However, a wide range of estimates exists, with high and low targets of $20.51 and $19.28, respectively, highlighting the market's uncertainty.
Candel Therapeutics Inc Stock (CADL) Year by Year Forecast
Candel Therapeutics Inc Stock (CADL) Price Forecast for 2024
Our forecast for CADL stock price in 2024 now indicates an average price target of $8.8155 with a high forecast of $16.47 and a low forecast of $1.16. The average prediction reflects an increase of +113.97% from the last recorded price of $4.12.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $5.9113 | $5.6813 | $6.8257 | +43.48% |
Candel Therapeutics Inc Stock (CADL) Price Forecast for 2025
Candel Therapeutics Inc Stock (CADL) is expected to reach an average price of $5.4237 in 2025, with a high prediction of $7.5434 and a low estimate of $3.304. This indicates an +31.64% rise from the last recorded price of $4.12.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $7.0351 | $5.3268 | $7.2851 | +70.75% |
| February, 2025 | $5.3761 | $5.2761 | $7.5434 | +30.49% |
| March, 2025 | $6.0572 | $4.8272 | $6.0572 | +47.02% |
| April, 2025 | $5.321 | $4.8455 | $6.0527 | +29.15% |
| May, 2025 | $5.0321 | $4.632 | $5.7921 | +22.14% |
| June, 2025 | $5.3032 | $4.8404 | $5.6932 | +28.72% |
| July, 2025 | $5.107 | $4.9842 | $6.107 | +23.96% |
| August, 2025 | $4.408 | $4.388 | $5.4698 | +6.99% |
| September, 2025 | $3.4291 | $3.3508 | $4.5808 | -16.77% |
| October, 2025 | $3.7729 | $3.3519 | $3.8829 | -8.42% |
| November, 2025 | $3.694 | $3.304 | $4.7685 | -10.34% |
| December, 2025 | $4.4873 | $3.5095 | $4.9751 | +8.92% |
Candel Therapeutics Inc Stock (CADL) Price Forecast for 2026
The predicted value for Candel Therapeutics Inc (CADL) in 2026 is set at an average of $3.6114. Estimates vary from a peak of $4.5206 to a trough of $2.7023, indicating an -12.34% surge from the present price of $4.12.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $3.8889 | $3.7889 | $4.5206 | -5.61% |
| February, 2026 | $3.37 | $3.36 | $4.0217 | -18.21% |
| March, 2026 | $3.371 | $3.241 | $3.561 | -18.18% |
| April, 2026 | $3.5348 | $3.1038 | $3.8221 | -14.20% |
| May, 2026 | $3.4459 | $3.4059 | $3.7759 | -16.36% |
| June, 2026 | $3.227 | $3.127 | $3.6886 | -21.68% |
| July, 2026 | $3.0508 | $2.9721 | $3.2825 | -25.95% |
| August, 2026 | $3.2319 | $3.0036 | $3.3791 | -21.56% |
| September, 2026 | $2.9457 | $2.8957 | $3.3083 | -28.50% |
| October, 2026 | $2.9365 | $2.854 | $3.254 | -28.72% |
| November, 2026 | $2.9478 | $2.7023 | $3.205 | -28.45% |
| December, 2026 | $3.4016 | $2.8289 | $3.5216 | -17.44% |
Candel Therapeutics Inc Stock (CADL) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Candel Therapeutics Inc (CADL) is $10.62, with a high forecast of $18.16 and a low forecast of $3.0844. This indicates an +157.85% increase from the last price of $4.12.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $3.4027 | $3.0844 | $3.5699 | -17.41% |
| February, 2027 | $3.3838 | $3.2382 | $3.4682 | -17.87% |
| March, 2027 | $3.7976 | $3.2965 | $4.0448 | -7.83% |
| April, 2027 | $3.6886 | $3.4459 | $3.8431 | -10.47% |
| May, 2027 | $8.5097 | $3.6714 | $13.51 | +106.55% |
| June, 2027 | $11.41 | $8.3026 | $11.57 | +176.97% |
| July, 2027 | $13.32 | $10.49 | $18.16 | +223.38% |
| August, 2027 | $13.30 | $12.69 | $14.41 | +222.70% |
| September, 2027 | $14.31 | $12.83 | $15.41 | +247.40% |
| October, 2027 | $12.29 | $11.77 | $14.45 | +198.18% |
| November, 2027 | $10.24 | $9.5361 | $12.18 | +148.48% |
| December, 2027 | $7.6749 | $7.5149 | $10.57 | +86.28% |
Candel Therapeutics Inc Stock (CADL) Price Forecast for 2028
In 2028, Candel Therapeutics Inc (CADL) is projected to reach an average price of $7.2792, with a high projection of $9.3368 and a low estimate of $5.2216. This indicates an +76.68% rise from the last price of $4.12.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $7.657 | $7.0204 | $8.5915 | +85.85% |
| February, 2028 | $8.1091 | $7.1036 | $9.0091 | +96.82% |
| March, 2028 | $8.4668 | $7.7846 | $9.3368 | +105.50% |
| April, 2028 | $7.1189 | $6.9334 | $8.5923 | +72.79% |
| May, 2028 | $7.1065 | $6.6344 | $7.8655 | +72.49% |
| June, 2028 | $6.9987 | $6.4585 | $7.5121 | +69.87% |
| July, 2028 | $7.0458 | $6.6808 | $7.6242 | +71.01% |
| August, 2028 | $7.7884 | $6.8384 | $7.9584 | +89.04% |
| September, 2028 | $6.7306 | $6.7306 | $7.964 | +63.36% |
| October, 2028 | $5.6927 | $5.2216 | $6.8761 | +38.17% |
| November, 2028 | $5.5303 | $5.2338 | $5.7463 | +34.23% |
| December, 2028 | $5.3225 | $5.2825 | $6.6669 | +29.19% |
Candel Therapeutics Inc Stock (CADL) Price Forecast for 2029
The 2029 price forecast for Candel Therapeutics Inc Stock (CADL) is $5.8173 on average, with a high prediction of $6.8901 and a low estimate of $4.7445. This represents an +41.20% increase from the previous price of $4.12.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $6.5001 | $5.208 | $6.8901 | +57.77% |
| February, 2029 | $5.9522 | $5.7522 | $6.4757 | +44.47% |
| March, 2029 | $5.4944 | $5.4944 | $6.1578 | +33.36% |
| April, 2029 | $5.2865 | $5.1854 | $5.5198 | +28.31% |
| May, 2029 | $5.4741 | $5.0576 | $5.7841 | +32.87% |
| June, 2029 | $5.4763 | $5.3852 | $5.6497 | +32.92% |
| July, 2029 | $5.2284 | $5.1429 | $5.7518 | +26.90% |
| August, 2029 | $5.076 | $4.9673 | $5.275 | +23.21% |
| September, 2029 | $5.3132 | $4.9866 | $5.3882 | +28.96% |
| October, 2029 | $5.1858 | $5.1548 | $5.3337 | +25.87% |
| November, 2029 | $4.968 | $4.888 | $5.334 | +20.58% |
| December, 2029 | $4.9931 | $4.7445 | $5.2501 | +21.19% |
Candel Therapeutics Inc Stock (CADL) Price Forecast for 2030
Candel Therapeutics Inc Stock (CADL) is expected to reach an average price of $12.37 in 2030, with a high forecast of $19.85 and a low forecast of $4.8877. This signifies an +200.25% surge from the last price of $4.12.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $5.0177 | $4.8877 | $5.151 | +21.79% |
| February, 2030 | $5.5499 | $4.9333 | $5.6399 | +34.71% |
| March, 2030 | $5.462 | $5.3164 | $5.5953 | +32.57% |
| April, 2030 | $5.9341 | $5.383 | $6.1186 | +44.03% |
| May, 2030 | $5.7118 | $5.5518 | $6.1396 | +38.63% |
| June, 2030 | $9.4039 | $5.6673 | $15.62 | +128.25% |
| July, 2030 | $13.05 | $9.3394 | $13.20 | +216.71% |
| August, 2030 | $12.92 | $12.70 | $19.85 | +213.63% |
| September, 2030 | $15.78 | $12.19 | $16.11 | +283.00% |
| October, 2030 | $16.19 | $14.39 | $17.12 | +292.99% |
| November, 2030 | $14.59 | $14.31 | $16.21 | +254.11% |
| December, 2030 | $13.04 | $11.27 | $15.05 | +216.57% |
1.80%
0.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):